Barry Hafkin
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 5
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 20
- Tuberculosis Research and Epidemiology 2
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 5
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 8
-
- Bacterial biofilms and quorum sensing 5
-
- Antimicrobial agents and applications 3
-
- Peripheral Neuropathies and Disorders 2
- Co-authors
- Dennis L. StevensVu LeNachum KaplanDonald H. BattsJohn L. HuntHarry LampirisDaniel HerrDavid J. Kuter
- Journals
- The Journal of Clinical Endocrinology & Metabolism (1 paper)Neurology (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesCanadaArgentina
In The Last Decade
Barry Hafkin
35 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 108
- Clinical Biochemistry 631
- Infectious Diseases 1.4k
- Molecular Medicine 354
- Applied Microbiology and Biotechnology 136
- Pharmacology 410
Countries citing papers authored by Barry Hafkin
This map shows the geographic impact of Barry Hafkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Hafkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Hafkin more than expected).
Fields of papers citing papers by Barry Hafkin
This network shows the impact of papers produced by Barry Hafkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Hafkin. The network helps show where Barry Hafkin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Barry Hafkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 7 | |
| 3 | 2017 | 43 | |
| 4 | 2015 | 9 | |
| 5 | 2015 | 13 | |
| 6 | 2015 | 41 | |
| 7 | 2013 | 37 | |
| 8 | 2013 | 27 | |
| 9 | 2013 | 29 | |
| 10 | 2012 | 92 | |
| 11 | 2009 | 66 | |
| 12 | 2002 | 332 | |
| 13 | 2002 | 409 | |
| 14 | 2001 | 114 | |
| 15 | 1997 | 56 | |
| 16 | 1997 | 30 | |
| 17 | 1997 | 9 | |
| 18 | 1996 | 17 | |
| 19 | 1982 | 77 | |
| 20 | 1982 | 21 |
About Barry Hafkin
Barry Hafkin is a scholar working on Infectious Diseases, Molecular Medicine and Clinical Biochemistry, having authored 35 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (20 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (5 papers), Bacterial Identification and Susceptibility Testing (5 papers), Bacterial biofilms and quorum sensing (5 papers), Antimicrobial agents and applications (3 papers), Tuberculosis Research and Epidemiology (2 papers) and Peripheral Neuropathies and Disorders (2 papers). The work is most often cited by research in Clinical Biochemistry (631 citations), Infectious Diseases (1.4k citations) and Molecular Medicine (354 citations). Barry Hafkin has collaborated with scholars based in United States, Canada and Argentina. Frequent co-authors include Dennis L. Stevens, Vu Le, Nachum Kaplan, Donald H. Batts, John L. Hunt, Harry Lampiris, Daniel Herr, David J. Kuter, Félix Arellano and Stanton L. Gerson. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.